# Pulse Wave Velocity, Pulse Wave Morphology and Blocking of the Reninangiotensin System in Patients With Chronic Kidney Disease

> **NCT00235287** · PHASE4 · UNKNOWN · sponsor: **Herlev Hospital** · enrollment: 60 (estimated)

## Conditions studied

- Kidney Failure, Chronic
- Cardiovascular Diseases

## Interventions

- **DRUG:** Candesartan and enalapril
- **DRUG:** candesartan and enalapril
- **DRUG:** candesartan and enalapril
- **DRUG:** candesartan and enalapril

## Key facts

- **NCT ID:** NCT00235287
- **Lead sponsor:** Herlev Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2005-09
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2009-01-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00235287

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00235287, "Pulse Wave Velocity, Pulse Wave Morphology and Blocking of the Reninangiotensin System in Patients With Chronic Kidney Disease". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT00235287. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*